Founders Capital Management Greenwich Life Sciences, Inc. Put Options Transaction History
Founders Capital Management
- $166 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GLSI
# of Institutions
49Shares Held
1.24MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$2.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA269KShares$2.53 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA139KShares$1.31 Million0.0% of portfolio
-
Credit Agricole S A87KShares$817,8000.0% of portfolio
-
Northern Trust Corp Chicago, IL82.8KShares$778,1220.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $121M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...